![Nataskia Lampe](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Nataskia Lampe worked as an Associate Director of Regulatory Affairs at Lung Biotechnology PBC.
She then worked at AbbVie, Inc. as an Asset Strategy Leader for Neuroscience & Fibrosis from 2018 to 2021.
In 2021, she became the Vice President & Head of Regulatory Affairs at Pieris Pharmaceuticals, Inc. Ms. Lampe received her undergraduate degree from Tulane University School of Medicine and her graduate degree from Thomas Jefferson University.
Eerdere bekende functies van Nataskia Lampe
| Bedrijven | Functie | Einde |
|---|---|---|
| PIERIS PHARMACEUTICALS | Algemeen Adviseur | 01-08-2022 |
| ABBVIE INC. | Corporate Officer/Principal | 01-08-2021 |
Lung Biotechnology PBC
 Lung Biotechnology PBC Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Algemeen Adviseur | - |
Opleiding van Nataskia Lampe
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
31
Eerstegraads connecties
5
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Thomas Jefferson University
 Thomas Jefferson University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AbbVie, Inc.
 AbbVie, Inc. Pharmaceuticals: MajorHealth Technology Engages in the research and development, manufacturing, commercialization & sale of immunology medicines and therapies | Health Technology |
Lung Biotechnology PBC
Lung Biotechnology PBC Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Tulane University School of Medicine
 Tulane University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pieris Pharmaceuticals, Inc.
 Pieris Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops and markets an anticalin-brand protein technology | Health Technology |
